^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    topotecan

    i
    Company:
    Generic mfg.
    Drug class:
    Topoisomerase I inhibitor
    Related drugs:
    Apply
    Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma (NCT06172296)
    Phase 3
    National Cancer Institute (NCI)
    Recruiting
    Last update posted :
    02/19/2025
    Initiation :
    04/19/2024
    Primary completion :
    12/31/2029
    Completion :
    12/31/2029
    ALK • TERT • MYCN
    |
    cisplatin • carboplatin • temozolomide • doxorubicin hydrochloride • cyclophosphamide • etoposide IV • irinotecan • vincristine • daunorubicin • topotecan • melphalan • thiotepa • Qarziba (dinutuximab beta) • Unituxin (dinutuximab) • dexrazoxane
    DAREONTM-9: A Study to Test How Well Different Doses of BI 764532 Are Tolerated by People With Small Cell Lung Cancer When Taken Together With a Single Agent Chemotherapy (NCT05990738)
    Phase 1
    Boehringer Ingelheim
    Recruiting
    Last update posted :
    02/18/2025
    Initiation :
    02/14/2024
    Primary completion :
    01/21/2026
    Completion :
    11/21/2026
    PD-L1
    |
    topotecan • obrixtamig (BI 764532)
    Study of Efficacy and Safety of Ribociclib (LEE011) in Combination With Topotecan and Temozolomide (TOTEM) in Pediatric Patients With Relapsed or Refractory Neuroblastoma and Other Solid Tumors (NCT05429502)
    Phase 1/2
    Novartis Pharmaceuticals
    Recruiting
    Last update posted :
    02/17/2025
    Initiation :
    12/27/2022
    Primary completion :
    10/15/2027
    Completion :
    01/28/2028
    MYCN • SMARCB1
    |
    IDH wild-type
    |
    temozolomide • Kisqali (ribociclib) • topotecan
    A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT (NCT04322318)
    Phase 2
    Children's Oncology Group
    Recruiting
    Last update posted :
    02/13/2025
    Initiation :
    10/19/2020
    Primary completion :
    07/01/2027
    Completion :
    07/01/2027
    TP53
    |
    carboplatin • doxorubicin hydrochloride • cyclophosphamide • ifosfamide • etoposide IV • irinotecan • vincristine • daunorubicin • topotecan
    Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL) (NCT03126916)
    Phase 3
    Children's Oncology Group
    Active, not recruiting
    Last update posted :
    02/13/2025
    Initiation :
    05/14/2018
    Primary completion :
    09/30/2026
    Completion :
    09/30/2026
    MYCN
    |
    MYCN amplification
    |
    cisplatin • Xalkori (crizotinib) • carboplatin • Lorbrena (lorlatinib) • doxorubicin hydrochloride • cyclophosphamide • etoposide IV • vincristine • topotecan • melphalan • thiotepa • Qarziba (dinutuximab beta) • busulfan • Unituxin (dinutuximab) • Azedra (iobenguane I 131) • Leukine (sargramostim) • captisol-enabled melphalan • cyclophosphamide intravenous • dexrazoxane
    Comparison of Standard of Care Treatment With a Triplet Combination of Targeted Immunotherapeutic Agents (NRG-GY023) (NCT04739800)
    Phase 2
    National Cancer Institute (NCI)
    Active, not recruiting
    Last update posted :
    02/10/2025
    Initiation :
    06/10/2021
    Primary completion :
    01/26/2023
    Completion :
    06/14/2025
    PD-L1 • BRCA1 • BRCA2
    |
    BRCA2 mutation • BRCA1 mutation
    |
    Avastin (bevacizumab) • Lynparza (olaparib) • Imfinzi (durvalumab) • paclitaxel • pegylated liposomal doxorubicin • topotecan • Recentin (cediranib) • Myocet (non-pegylated liposomal doxorubicin) • Duomeisu (pegylated liposomal doxorubicin) • doxorubicin liposomal
    Trametinib in Treating Patients With Recurrent or Progressive Low-Grade Ovarian Cancer or Peritoneal Cavity Cancer (NCT02101788)
    Phase 2/3
    National Cancer Institute (NCI)
    Active, not recruiting
    Last update posted :
    02/06/2025
    Initiation :
    02/27/2014
    Primary completion :
    04/04/2019
    Completion :
    10/11/2025
    BRAF
    |
    Mekinist (trametinib) • paclitaxel • letrozole • pegylated liposomal doxorubicin • topotecan • Myocet (non-pegylated liposomal doxorubicin) • Duomeisu (pegylated liposomal doxorubicin) • Soltamox (tamoxifen citrate) • doxorubicin liposomal
    Testing of Tazemetostat in Combination With Topotecan and Pembrolizumab in Patients With Recurrent Small Cell Lung Cancer (NCI-2022-03215) (NCT05353439)
    Phase 1
    National Cancer Institute (NCI)
    Suspended
    Last update posted :
    01/28/2025
    Initiation :
    07/27/2022
    Primary completion :
    04/01/2025
    Completion :
    04/01/2025
    CD4
    |
    Keytruda (pembrolizumab) • Tazverik (tazemetostat) • topotecan • Pembroria (pembrolizumab biosimilar)
    A Study of MORAb-202 Versus Investigator's Choice Chemotherapy in Female Participants With Platinum-resistant High-grade Serous (HGS) Ovarian, Primary Peritoneal, or Fallopian Tube Cancer (CA116-001) (NCT05613088)
    Phase 2
    Bristol-Myers Squibb
    Active, not recruiting
    Last update posted :
    11/21/2024
    Initiation :
    02/01/2023
    Primary completion :
    06/05/2024
    Completion :
    10/11/2026
    FOLR1
    |
    paclitaxel • pegylated liposomal doxorubicin • topotecan • farletuzumab ecteribulin (MORAb-202)
    Phase 2 Study of Alisertib Therapy for Rhabdoid Tumors (SJATRT) (NCT02114229)
    Phase 2
    St. Jude Children's Research Hospital
    Active, not recruiting
    Last update posted :
    10/31/2024
    Initiation :
    05/14/2014
    Primary completion :
    09/01/2025
    Completion :
    09/01/2027
    SMARCB1
    |
    SMARCA4 mutation
    |
    cisplatin • carboplatin • cyclophosphamide • etoposide IV • vincristine • topotecan • alisertib (MLN8237) • cyclophosphamide intravenous
    A Study of N9 Chemotherapy in Children With Neuroblastoma (NCT04947501)
    Phase 1
    Memorial Sloan Kettering Cancer Center
    Recruiting
    Last update posted :
    06/11/2024
    Initiation :
    06/22/2021
    Primary completion :
    06/22/2025
    Completion :
    06/22/2025
    MYCN
    |
    MYCN amplification
    |
    carboplatin • doxorubicin hydrochloride • cyclophosphamide • ifosfamide • etoposide IV • vincristine • topotecan • mesna • cyclophosphamide intravenous
    Study Of Palbociclib Combined With Chemotherapy In Pediatric Patients With Recurrent/Refractory Solid Tumors (NCT03709680)
    Phase 1/2
    Pfizer
    Active, not recruiting
    Last update posted :
    05/22/2024
    Initiation :
    05/24/2019
    Primary completion :
    06/24/2024
    Completion :
    02/25/2025
    EWSR1 • FUS
    |
    Ibrance (palbociclib) • temozolomide • cyclophosphamide • irinotecan • topotecan • cyclophosphamide intravenous
    Testing the Combination of Cediranib and Olaparib in Comparison to Each Drug Alone or Other Chemotherapy in Recurrent Platinum-Resistant Ovarian Cancer (COCOS) (NCT02502266)
    Phase 2/3
    National Cancer Institute (NCI)
    Active, not recruiting
    Last update posted :
    05/21/2024
    Initiation :
    05/03/2016
    Primary completion :
    06/30/2024
    Completion :
    06/30/2024
    BRCA1 • BRCA2 • BRCA • MUC16
    |
    BRCA2 mutation • BRCA1 mutation • BRCA mutation
    |
    Lynparza (olaparib) • paclitaxel • pegylated liposomal doxorubicin • topotecan • Recentin (cediranib) • Myocet (non-pegylated liposomal doxorubicin) • Duomeisu (pegylated liposomal doxorubicin) • doxorubicin liposomal
    9-ING-41 in Pediatric Patients With Refractory Malignancies. (NCT04239092)
    Phase 1
    Actuate Therapeutics Inc.
    Recruiting
    Last update posted :
    05/15/2024
    Initiation :
    06/05/2020
    Primary completion :
    12/01/2024
    Completion :
    12/01/2024
    AFP
    |
    temozolomide • cyclophosphamide • irinotecan • topotecan • elraglusib (9-ING-41) • cyclophosphamide intravenous
    REFRaME-O1: A Study to Investigate the Efficacy and Safety of Luveltamab Tazevibulin Versus Investigator's Choice (IC) Chemotherapy in Women With Ovarian Cancer (Including Fallopian Tube or Primary Peritoneal Cancers) Expressing FOLR1 (NCT05870748)
    Phase 2/3
    Sutro Biopharma, Inc.
    Recruiting
    Last update posted :
    04/19/2024
    Initiation :
    07/12/2023
    Primary completion :
    09/01/2025
    Completion :
    02/01/2026
    FOLR1
    |
    FOLR1 expression • FOLR1 positive
    |
    gemcitabine • paclitaxel • pegylated liposomal doxorubicin • topotecan • luveltamab tazevibulin (STRO-002) • Neulasta (pegfilgrastim)
    Dinutuximab, Sargramostim, and Combination Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma (NCI-2018-03732) (NCT03786783)
    Phase 2
    National Cancer Institute (NCI)
    Active, not recruiting
    Last update posted :
    04/17/2024
    Initiation :
    03/04/2019
    Primary completion :
    12/31/2021
    Completion :
    09/22/2024
    MYCN • IL6 • CXCL9
    |
    MYCN amplification • IL6 expression
    |
    cisplatin • carboplatin • doxorubicin hydrochloride • cyclophosphamide • etoposide IV • vincristine • daunorubicin • topotecan • melphalan • thiotepa • Qarziba (dinutuximab beta) • Unituxin (dinutuximab) • Leukine (sargramostim) • cyclophosphamide intravenous • dexrazoxane
    A Study Evaluating the Safety, Tolerability, Pharmacokinetics and Preliminary Activity of Idasanutlin in Combination With Either Chemotherapy or Venetoclax in Treatment of Pediatric and Young Adult Participants With Relapsed/Refractory Acute Leukemias or Solid Tumors (NCT04029688)
    Phase 1/2
    Hoffmann-La Roche
    Active, not recruiting
    Last update posted :
    03/29/2024
    Initiation :
    01/27/2020
    Primary completion :
    12/30/2025
    Completion :
    12/30/2025
    TP53
    |
    TP53 wild-type
    |
    Venclexta (venetoclax) • cytarabine • cyclophosphamide • topotecan • idasanutlin (RG7388) • fludarabine IV • cyclophosphamide intravenous
    Dose Attenuated Chemotherapy in Compromised Patients With Lung Cancer (NCT05800587)
    Phase 2
    Fox Chase Cancer Center
    Recruiting
    Last update posted :
    03/26/2024
    Initiation :
    02/22/2023
    Primary completion :
    08/01/2028
    Completion :
    08/01/2029
    CD4
    |
    carboplatin • gemcitabine • docetaxel • albumin-bound paclitaxel • pemetrexed • etoposide IV • irinotecan • topotecan • Zepzelca (lurbinectedin)
    Busulfan, Melphalan, and Stem Cell Transplant After Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma (NCT01798004)
    Phase 1
    Children's Oncology Group
    Active, not recruiting
    Last update posted :
    03/13/2024
    Initiation :
    04/08/2013
    Primary completion :
    07/28/2015
    MYCN
    |
    MYCN amplification • MYCN expression
    |
    cisplatin • doxorubicin hydrochloride • cyclophosphamide • etoposide IV • vincristine • topotecan • melphalan • mesna • busulfan • Neupogen (filgrastim) • cyclophosphamide intravenous
    Veliparib and Topotecan Hydrochloride in Treating Patients With Solid Tumors, Relapsed or Refractory Ovarian Cancer, or Primary Peritoneal Cancer (NCT01012817)
    Phase 1/2
    National Cancer Institute (NCI)
    Active, not recruiting
    Last update posted :
    03/05/2024
    Initiation :
    11/03/2009
    Primary completion :
    01/13/2019
    Completion :
    08/30/2024
    BRCA1 • BRCA2
    |
    BRCA mutation
    |
    veliparib (ABT-888) • topotecan
    Trial of Topotecan With VX-970 (M6620), an ATR Kinase Inhibitor, in Small Cell Cancers and Extrapulmonary Small Cell Cancers (NCT02487095)
    Phase 1/2
    National Cancer Institute (NCI)
    Active, not recruiting
    Last update posted :
    03/05/2024
    Initiation :
    07/30/2015
    Primary completion :
    02/24/2021
    Completion :
    10/30/2025
    EGFR • ALK
    |
    EGFR mutation • ALK translocation
    |
    berzosertib (M6620) • topotecan
    Therapy for Children With Advanced Stage Neuroblastoma (NCT01857934)
    Phase 2
    St. Jude Children's Research Hospital
    Active, not recruiting
    Last update posted :
    01/15/2024
    Initiation :
    07/05/2013
    Primary completion :
    10/21/2021
    Completion :
    12/01/2024
    MYCN
    |
    MYCN amplification
    |
    cisplatin • doxorubicin hydrochloride • cyclophosphamide • etoposide IV • vincristine • topotecan • melphalan • mesna • Proleukin (aldesleukin) • busulfan • Unituxin (dinutuximab) • Leukine (sargramostim) • Neupogen (filgrastim) • cyclophosphamide intravenous • humanised dinutuximab (Hu14.18K322A)
    Induction Therapy Including 131 I-MIBG and Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma Undergoing Stem Cell Transplant, Radiation Therapy, and Maintenance Therapy With Isotretinoin (NCT01175356)
    Phase 1
    Children's Oncology Group
    Active, not recruiting
    Last update posted :
    01/04/2024
    Initiation :
    10/04/2010
    Primary completion :
    09/28/2016
    Completion :
    09/28/2024
    MYCN
    |
    MYCN amplification
    |
    cisplatin • doxorubicin hydrochloride • cyclophosphamide • etoposide IV • vincristine • topotecan • melphalan • busulfan • Azedra (iobenguane I 131) • cyclophosphamide intravenous
    Clinical Trial of SP-2577 (Seclidemstat) in Patients With Relapsed or Refractory Ewing or Ewing-related Sarcomas (SALA-002-EW16) (NCT03600649)
    Phase 1
    Salarius Pharmaceuticals, LLC
    Active, not recruiting
    Last update posted :
    11/21/2023
    Initiation :
    06/04/2018
    Primary completion :
    09/01/2025
    Completion :
    12/01/2025
    EWSR1
    |
    cyclophosphamide • topotecan • seclidemstat (SP2577)
    Phase 1/2a/3 Evaluation of Adding AL3818 to Standard Platinum-Based Chemotherapy in Subjects With Recurrent or Metastatic Endometrial, Ovarian, Fallopian, Primary Peritoneal or Cervical Carcinoma (AL3818-US-002) (NCT02584478)
    Phase 3
    Advenchen Laboratories, LLC
    Active, not recruiting
    Last update posted :
    11/08/2023
    Initiation :
    12/01/2015
    Primary completion :
    10/01/2024
    Completion :
    12/01/2024
    BRCA
    |
    BRCA mutation
    |
    carboplatin • paclitaxel • Focus V (anlotinib) • pegylated liposomal doxorubicin • topotecan
    Comparing Standard of Care Chemotherapy Treatment to the Combination of Copanlisib and Olaparib for Recurrent Platinum Resistant Ovarian Cancer That Has Progressed Through PARP Inhibitor Therapy (NRG-GY029) (NCT05295589)
    Phase 2
    National Cancer Institute (NCI)
    Withdrawn
    Last update posted :
    09/26/2023
    Initiation :
    06/30/2022
    Primary completion :
    03/17/2023
    Completion :
    03/17/2023
    BRCA1 • BRCA2 • HRD • MUC16
    |
    BRCA2 mutation • HRD
    |
    Lynparza (olaparib) • paclitaxel • Aliqopa (copanlisib) • pegylated liposomal doxorubicin • topotecan • Myocet (non-pegylated liposomal doxorubicin) • Duomeisu (pegylated liposomal doxorubicin)
    Durvalumab and Lurbinectedin for the Treatment of Relapsed or Refractory Small Cell Lung Cancer (NCT04607954)
    Phase 2
    Mayo Clinic
    Recruiting
    Last update posted :
    07/24/2023
    Initiation :
    12/04/2020
    Primary completion :
    11/01/2024
    Completion :
    11/01/2025
    PD-L1
    |
    Imfinzi (durvalumab) • topotecan • Zepzelca (lurbinectedin)
    Comparison of Three Treatment Regimens in Treating Patients With Relapsed or Refractory Acute Myelogenous Leukemia (NCT00005962)
    Phase 2
    Eastern Cooperative Oncology Group
    Completed
    Last update posted :
    06/22/2023
    Initiation :
    10/04/2000
    Primary completion :
    10/01/2005
    Completion :
    06/01/2007
    CD33
    |
    CD33 positive
    |
    cyclophosphamide • Mylotarg (gemtuzumab ozogamicin) • daunorubicin • topotecan • Leukine (sargramostim)
    A Study of Mirvetuximab Soravtansine vs. Investigator's Choice of Chemotherapy in Platinum-Resistant, Advanced High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers With High Folate Receptor-Alpha Expression (MIRASOL) (NCT04209855)
    Phase 3
    ImmunoGen, Inc.
    Active, not recruiting
    Last update posted :
    03/06/2023
    Initiation :
    12/31/2019
    Primary completion :
    09/01/2023
    Completion :
    04/01/2024
    FOLR1
    |
    FOLR1 expression
    |
    paclitaxel • pegylated liposomal doxorubicin • Elahere (mirvetuximab soravtansine-gynx) • topotecan • doxorubicin liposomal
    Cabozantinib With Topotecan-Cyclophosphamide (NCT04661852)
    Phase 1
    Dana-Farber Cancer Institute
    Completed
    Last update posted :
    02/15/2023
    Initiation :
    12/23/2020
    Primary completion :
    10/24/2022
    Completion :
    10/24/2022
    EWSR1 • FLI1 • FUS
    |
    Cabometyx (cabozantinib tablet) • cyclophosphamide • Cometriq (cabozantinib capsule) • topotecan • Neulasta (pegfilgrastim) • Neupogen (filgrastim) • cyclophosphamide intravenous
    Safety and Tolerability Evaluation Study of BVAC-C in Patients With HPV Type 16 or 18 Positive Cervical Cancer (BVAC-C-P1) (NCT02866006)
    Phase 1/2
    Cellid Co., Ltd.
    Completed
    Last update posted :
    10/12/2022
    Initiation :
    10/01/2016
    Primary completion :
    12/01/2021
    Completion :
    06/01/2022
    CD4
    |
    topotecan • BVAC-C
    Balstilimab Versus Investigator Choice Chemotherapy in Patients With Recurrent Cervical Cancer (BRAVA) (NCT04943627)
    Phase 3
    Agenus Inc.
    Withdrawn
    Last update posted :
    10/05/2022
    Initiation :
    08/02/2021
    Primary completion :
    10/22/2021
    Completion :
    10/22/2021
    PD-L1
    |
    PD-L1 expression
    |
    gemcitabine • pemetrexed • irinotecan • vinorelbine tartrate • topotecan • balstilimab (AGEN2034)
    Comparing Two Different Myeloablation Therapies in Treating Young Patients Who Are Undergoing a Stem Cell Transplant for High-Risk Neuroblastoma (NCT00567567)
    Phase 3
    Children's Oncology Group
    Completed
    Last update posted :
    04/28/2022
    Initiation :
    11/05/2007
    Primary completion :
    02/27/2015
    Completion :
    03/31/2022
    CD8 • MYCN • UGT1A1 • CD4
    |
    MYCN amplification • UGT1A1*1*1
    |
    cisplatin • carboplatin • doxorubicin hydrochloride • cyclophosphamide • etoposide IV • topotecan • melphalan • Marqibo (vincristine liposomal) • thiotepa • Neupogen (filgrastim) • cyclophosphamide intravenous
    Trial on NIraparib-TSR-042 (Dostarlimab) vs Physician's Choice CHEmotherapy in Recurrent, Ovarian, Fallopian Tube or Primary Peritoneal Cancer Patients Not Candidate for Platinum Retreatment (NItCHE) (NCT04679064)
    Phase 3
    Fondazione Policlinico Universitario Agostino G...
    Recruiting
    Last update posted :
    08/27/2021
    Initiation :
    12/01/2020
    Primary completion :
    01/01/2025
    Completion :
    01/01/2025
    MUC16
    |
    Avastin (bevacizumab) • gemcitabine • paclitaxel • Zejula (niraparib) • Jemperli (dostarlimab-gxly) • pegylated liposomal doxorubicin • topotecan • doxorubicin liposomal
    Trial on Trabectedin (ET-743) vs Clinician's Choice Chemotherapy in Recurrent Ovarian, Primary Peritoneal or Fallopian Tube Cancers of BRCA Mutated or BRCAness Phenotype Patients (Mito23) (NCT02903004)
    Phase 3
    Fondazione Policlinico Universitario Agostino G...
    Completed
    Last update posted :
    08/25/2021
    Initiation :
    04/11/2016
    Primary completion :
    12/20/2018
    Completion :
    12/20/2018
    BRCA • MUC16
    |
    BRCA mutation
    |
    carboplatin • gemcitabine • paclitaxel • pegylated liposomal doxorubicin • Yondelis (trabectedin) • topotecan • doxorubicin liposomal
    Combination Chemotherapy and Surgery With or Without Isotretinoin in Treating Young Patients With Neuroblastoma (NCT00499616)
    Phase 3
    Children's Oncology Group
    Completed
    Last update posted :
    07/06/2021
    Initiation :
    10/08/2007
    Primary completion :
    06/30/2014
    Completion :
    06/30/2021
    MYCN
    |
    carboplatin • doxorubicin hydrochloride • cyclophosphamide • etoposide IV • topotecan • Neupogen (filgrastim) • cyclophosphamide intravenous
    Study Comparing Rovalpituzumab Tesirine Versus Topotecan in Subjects With Advanced or Metastatic Small Cell Lung Cancer With High Levels of Delta-like Protein 3 (DLL3) and Who Have First Disease Progression During or Following Front-line Platinum-based Chemotherapy (TAHOE) (NCT03061812)
    Phase 3
    AbbVie
    Completed
    Last update posted :
    02/23/2021
    Initiation :
    04/11/2017
    Primary completion :
    02/12/2020
    Completion :
    02/12/2020
    DLL3
    |
    DLL3 expression
    |
    dexamethasone • topotecan • Rova-T (rovalpituzumab tesirine)
    A Study of Mirvetuximab Soravtansine vs. Investigator's Choice of Chemotherapy in Women With Folate Receptor (FR) Alpha Positive Advanced Epithelial Ovarian Cancer (EOC), Primary Peritoneal or Fallopian Tube Cancer (FORWARD I) (NCT02631876)
    Phase 3
    ImmunoGen, Inc.
    Completed
    Last update posted :
    10/14/2020
    Initiation :
    03/02/2016
    Primary completion :
    01/01/2019
    Completion :
    01/01/2020
    FOLR1
    |
    FOLR1 positive
    |
    paclitaxel • pegylated liposomal doxorubicin • Elahere (mirvetuximab soravtansine-gynx) • topotecan • doxorubicin liposomal
    Simvastatin With Topotecan and Cyclophosphamide in Relapsed and/or Refractory Pediatric Solid and CNS Tumors (AflacST1402) (NCT02390843)
    Phase 1
    Emory University
    Completed
    Last update posted :
    04/03/2020
    Initiation :
    02/01/2015
    Primary completion :
    09/22/2019
    Completion :
    09/22/2019
    STAT3 • IL6R
    |
    cyclophosphamide • topotecan • simvastatin • cyclophosphamide intravenous
    Clinical Trial of Lurbinectedin (PM01183) in Platinum Resistant Ovarian Cancer Patients (CORAIL) (NCT02421588)
    Phase 3
    PharmaMar
    Completed
    Last update posted :
    04/03/2020
    Initiation :
    05/01/2015
    Primary completion :
    10/12/2018
    Completion :
    10/12/2018
    MUC16
    |
    pegylated liposomal doxorubicin • topotecan • Zepzelca (lurbinectedin)